This article covers the advances being made in individualized (patient-specific) cancer vaccines as well as the science behind them. Most of this generation of vaccines will be used following radiation and chemotherapy to clear residual cancer cells from the body, but the potential exists for future vaccines that would replace chemo entirely.
New Cancer Vaccine Kills Lymphoma, Now in Phase III Clinical Trials | Singularity Hub
Accentia Biopharmaceuticals and Biovest International have developed a non-Hodgkin?s lymphoma (NHL) vaccine that teaches the body?s immune system to identify and destroy tumor cells while leaving healthy tissue intact. The vaccine, called BiovaxID, is already in Phase III clinical trials.
Comments
Add Comment